M&A Activity During Q2 Declined In Volume And Valuation

 
• By Joseph Haas
  
Quarterly report
Q2 2024 saw a decline in M&A volume and valuation compared to Q1 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business